The recalled product, packaged in single dose 10ml vials, can be identified from its lot code, '24020027,' and expiry date, December 2025. It also has the national drug code (NDC) '81284-213-01.' ...

This leaflet answers some common questions about insulin 10 mL vials. It does not contain all the available information. It does not take the place of talking to your doctor, diabetes education ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

According to a company statement, Glenmark Pharmaceuticals Inc., USA, an arm of the company, has launched the Epinephrine injection of strength 10 mg/10 mL (1 mg/mL) multiple-dose vial.

Glenmark Pharma launches epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial: Our Bureau, Mumbai Thursday, February 27, 2025, 12:30 Hrs [IST] Glenmark Pharmaceutic ...

Each unit is a single vessel into which sample vials are placed, with the CAT 7 supporting 10 ml vials, the CAT 18, 2 ml vials, and the CAT 24 holding 4 ml vials. The sample vials within the CAT ...

Mahwah: Glenmark Pharmaceuticals Inc., USA has announced the launch of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) ...

Glenmark Pharmaceuticals has launched a generic version of Epinephrine injection multiple-dose vial in the US, gaining 180 days of CGT exclusivity. The injection treats hypotension from septic shock ...

Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting insulin biosimilars approved by the FDA in 2021. Merilog, a rapid-acting human insulin analog, is the first ...

1Glenmark's Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial is only approved for the indication(s) listed in Glenmark's approved label. 2Market includes brand and all available ...